I guess Trump forgets that he had control over the Senate &

New Post Public Reply Private Reply Replies (0) Message Board
reindeer830
207
I guess Trump forgets that he had control over the Senate & House for his first 2 years in office and has had Moscow Mitch & the Rep Senate in his pocket every day he has been in office. But, we all know that it is always someone else's fault why he can't get anything done. Still waiting for Mexico to pay for the Wall and China to pay the tariffs.



WASHINGTON — The most powerful man in the world prefers to portray himself as a martyr.

President Donald Trump says he's been beset on all sides by sinister forces that are oppressing him and depriving him of the authority he needs to deliver on his vision for America.

Often, the villains in his narratives work for him.

First, it was the CIA and the FBI, then Democrats, members of his Cabinet and Robert Mueller. Lately, his enemies list includes his hand-picked Federal Reserve chairman, Jay Powell, and Fox News. The cable network "isn't working for us anymore," Trump declared in a tweet last week, a few days after calling Powell an "enemy" of the United States.

Trump's persecution complex is an essential part of his brand — one that resonates deeply with a political base that believes anti-Trump liberals run the federal government and the news media. But as he seeks re-election in 2020, Trump is banking heavily on his ability to blend it into a coherent narrative with a version of his presidency in which he's been a commanding force, steamrolling adversaries to get things done.

"This election is not merely a verdict on the amazing progress we've made," Trump said when he kicked off his re-election campaign in Orlando, Florida, in June. "It's a verdict on the un-American conduct of those who tried to undermine our great democracy, and undermine you."



'I'm all in': Why voters in this Florida swing county still support Trump
AUG. 29, 201903:14
When he's less scripted, Trump sometimes speaks or tweets in terms that are more personal, such as when he describes himself as the target of "presidential harassment."

These two halves of Trump — victim and conqueror — fit together snugly for his campaign.

"It definitely is something that he and the campaign talk about," said Tim Murtaugh, communications director for Trump's re-election campaign. "There is no question he can still run against Washington based on the outspoken and unprecedented obstruction he has faced. And despite all of this, he has still accomplished everything that he has on behalf of the country."

Trump's supporters have mirrored the messaging.

Conservative commentator Bill Mitchell, for example, has cast Silicon Valley and the Drudge Report as anti-Trump forces tilting the world unfairly against him in recent days while also praising those — implicitly Trump — who overcome such challenges.

"Big Tech doesn't even care any more. They are all in to steal this election from President Trump. The days of appearing fair are over. They are just daring Trump to stop them at this point," he wrote in a tweet just hours after posting, "Let's start here: Life ain't fair. Proceed as if you know it. Be a champion, not a victim. Victims see roadblocks, champions see opportunities. #Trump2020."

Democrats say Trump's case requires a cognitive dissonance that is too much to bear.

"Playing the victim card in politics is pretty tough when you're president of the United States," said Chris Kofinis, a Democratic strategist and message-testing expert who has worked on presidential campaigns. "You can’t have it both ways. You either have control over the destiny of the country or you don’t. I think it’s that simple."

The Washington Trump is running against, critics note, is filled with people he appointed to run agencies that are under his control. The Senate has been in Republican hands throughout his presidency. And the Supreme Court has a conservative majority featuring two justices he appointed.

To the extent he's been frustrated by what he calls "the swamp," it has arguably been as much a result of his inability to get people in his own administration and in his own party to go along with policies that sometimes cross the border of seriousness — like nuking hurricanes — as it has been from an opposition Democratic Party that has held very little formal power since he swept into office in January 2017.

While Trump surely has racked up significant policy and political victories — a major tax cut, two Supreme Court appointments and deregulation of an array of industries — his trade war with China has caused economic pain for producers and consumers in the U.S., he's demonstrated no progress in dealing with the regimes in North Korea and Iran despite his focus on those countries, and the massive influx of immigrants from Latin America on his watch has resulted in a humanitarian crisis.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

BioCryst Pharmaceuticals Reports Positive Outcomes for ORLADEYO

Updated Category News Views 62

BioCryst Pharmaceuticals Highlights ORLADEYO's Impact BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has unveiled a compelling study that underscores how ORLADEYO (berotralstat) significantly lowers healthcare resource utilization (HRU) for patients battling hereditary angioedema (HAE). This innovative oral treatment has garnered attention due to its remarkable findings,...

Continue Reading
Man Group PLC Discloses Interest in Spectris plc Shares

Updated Category News Views 174

Understanding Man Group PLC's Position Disclosure Man Group PLC is making headlines as it officially discloses its holdings in Spectris plc. This disclosure is known as FORM 8.3 and is a crucial document under Rule 8.3 of the Takeover Code. It indicates the shareholding interests of Man Group in Spectris, representing a significant percentage of the company's relevant...

Continue Reading
Centessa Pharmaceuticals Seeks $225 Million Through Public Offering

Updated Category News Views 91

Centessa Pharmaceuticals Launches Major $225 Million Offering Centessa Pharmaceuticals plc (NASDAQ: CNTA), an innovative clinical-stage pharmaceutical company, has announced an ambitious public offering with the goal of raising around $225 million. This offering features 15,254,237 American Depositary Shares (ADSs), each representing one ordinary share, priced at $14.75...

Continue Reading
Unveiling Software Giants: Microsoft and Its Rivals in 2024

Updated Category News Views 350

Understanding the Competitive Landscape of Software Giants In the dynamic world of software, staying informed about leading companies is vital for investors and analysts alike. This article focuses on Microsoft (NASDAQ: MSFT) and its primary competitors, aiming to deliver a thorough analysis of financial statistics, market standings, and opportunities for growth within...

Continue Reading
Harris Leads Trump by 3 Points in Key Election Polls

Updated Category News Views 105

Election Polls Show Harris's Slim Lead Over Trump In the battleground of the upcoming U.S. presidential election, Democratic Vice President Kamala Harris has established a slender lead over Republican contender Donald Trump, according to the latest polling data. Recent surveys indicate that Harris is ahead by a margin of 3 points, with her support reaching 45% compared to...

Continue Reading